XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Xtant Medical Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.29+0.00 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $40.82M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.4191 (−59.02%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Xtant Medical Holdings, Inc. saw revenue fall 14.3% to $109.53M over the twelve months to Jun 30, 2026. Operating income fell 37582.1% to -$10.50M, moving the operating margin from 0.0% to -9.6%. Free cash flow was -$696.00K.
Revenue
$109.53M
-14.3% vs. a year earlier
Operating income
-$10.50M
-37582.1% vs. a year earlier
Free cash flow
-$696.00K
TTM Q2 2026
EPS, diluted
-$0.08
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $40.82M
- P/E ratio
- –
- Price to sales
- 0.37
- Price to book
- 1.02
- Dividend yield
- –
- Free cash flow yield
- -1.71%
Fundamentals
- Revenue
- $109.53M
- Net income
- -$11.14M
- EPS, diluted
- -$0.08
- Free cash flow
- -$696.00K
- Book value per share
- $0.29
- Diluted shares
- 140M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$109.53M-14.3% YoY
Gross profit
$65.05M-15.4% YoY
Operating income
-$10.50M-37582.1% YoY
Net income
-$11.14M
EPS, diluted
-$0.08
Free cash flow
-$696.00K
Reported periodTrailing twelve months